US signs $71M health deal with Angola
The U.S. signed a five‑year, $71 million health cooperation agreement with Angola under the current administration’s global health strategy, extending America’s bilateral public‑health footprint in Africa. That allocation reflects a strategic, country‑level approach to health diplomacy and capacity building. (state.gov)
The State Department press statement announcing the bilateral health cooperation memorandum was issued by Principal Deputy Spokesperson Thomas “Tommy” Pigott on March 19, 2026. (state.gov)) The Angolan government committed a $50 million counterpart investment to the agreement, and specified that 30% of that Angolan contribution will be dedicated to essential laboratory and health commodities. (state.gov)) The MOU identifies HIV, malaria, and global health security as the priority program areas targeted for joint U.S.–Angolan work under the agreement. (state.gov)) The document explicitly promotes private‑sector integration, calling for leveraging both U.S. and Angolan companies to bolster health‑system functions including human resources, data management, and supply‑chain capacity. (state.gov)) The State Department said the agreement will be executed “working with Congress,” indicating congressional coordination and appropriation will factor into the implementation pathway. (state.gov)) Kaiser Family Foundation’s tracker of America First bilateral MOUs lists the Angola deal among recent signings and notes that implementation of these MOUs is slated for later in 2026. (kff.org)) U.S. public‑health agencies already working in Angola—such as CDC programs focused on laboratory strengthening and surveillance—are positioned as likely technical partners for the MOU’s laboratory and health‑security components. (cdc.gov))
